4
Changes in Ownership
Minerva Neurosciences, Inc. Filed Acc 0001209191-18-063187
CEO sold 2,604 shares at $7.46 ($19,426)
- CEO acquired 18,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Luthringer Remy CEO | 2018-12-14 | Option exercise | +18,750 | 35,306 | D | ||
| Luthringer Remy CEO | 2018-12-17 | Sale | −2,604 | $7.46 | $19,426 | 32,702 | D |
| Derivatives | |||||||
| Luthringer Remy CEO | 2018-12-14 | Option exercise · Restricted Stock Unit | −18,750 | 37,500 | D | ||
| Open-market sales · 2,604 sh · avg $7.46 · $19,426 | |||||||
Loading xslF345X03/doc4.xml…